Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
Clinical Study on the Safety and Effectiveness of low-dose chidamide maintenance therapy after allogeneic hematopoietic stem cell transplantation for T-cell acute lymphoblastic leukemia or T-cell lymphomas.
Epistemonikos ID: d1ff2b05e37510ccb49e736ea2128a7748c9fa8d
First added on: May 15, 2024